 | Up a level |
Boyer, David; Hu, Allen; Warrow, David; Xavier, Samantha; Gonzalez, Victor; Lad, Eleonora; Rosen, Richard B; Do, Diana; Schneiderman, Todd; Hu, Allen; Munk, Marion R; Jaffe, Glenn; Tedford, Stephanie E; Croissant, Cindy L; Walker, Michael; Rückert, Rene; Tedford, Clark E (2024). LIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative (Dry) Age-Related Macular Degeneration Using the LumiThera Valeda Light Delivery System. Retina, 44(3), pp. 487-497. Wolters Kluwer 10.1097/IAE.0000000000003980
Joussen, Antonia M; Wolf, Sebastian; Kaiser, Peter K; Boyer, David; Schmelter, Thomas; Sandbrink, Rupert; Zeitz, Oliver; Deeg, Gesa; Richter, Annett; Zimmermann, Torsten; Hoechel, Joachim; Buetehorn, Ulf; Schmitt, Walter; Stemper, Brigitte; Boettger, Michael K (2019). The Developing Regorafenib Eye drops for neovascular Age-related Macular degeneration (DREAM) study: an open-label phase II trial. British journal of clinical pharmacology, 85(2), pp. 347-355. Wiley-Blackwell 10.1111/bcp.13794
Jaffe, Glenn J; Schmitz-Valckenberg, Steffen; Boyer, David; Heier, Jeffrey; Wolf-Schnurrbusch, Ute; Staurenghi, Giovanni; Schmidt-Erfurth, Ursula; Holz, Frank G (2015). Randomized Trial to Evaluate Tandosporine in Geographic Atrophy Secondary to Age-Related Macular Degeneration: the GATE Study. American journal of ophthalmology, 160(6), pp. 1226-1234. Elsevier Science 10.1016/j.ajo.2015.08.024
